Add Yahoo as a preferred source to see more of our stories on Google. New research from Boston University shows that as BMI rises, so does the chance of low back pain, with risk climbing steadily up ...

A new weight-loss drug that Eli Lilly is testing is helping patients in a late-stage trial lose an average of 28.7% of their body weight and offered "substantial" relief from osteoarthritis pain. In ...

Research has shown that there is a relationship between obesity and developing degenerative arthritis, and spine degeneration due to mechanical and inflammatory factors. Weight loss is thought to ...

Low back pain (LBP) is a prevalent condition associated with disability, work loss and economic burden to healthcare. Significant risk factors include poor sleep, physical and psychological stress, ...

(Boston)—Low back pain (LBP) is a prevalent condition associated with disability, work loss and economic burden to healthcare. Significant risk factors include poor sleep, physical and psychological ...

In a phase 3 trial, Eli Lilly’s experimental drug retatrutide delivered an average 28.7% weight loss and reduced pain among adults with obesity or overweight and knee osteoarthritis. The trial ...

My back’s been bothering me, and everyone seems to have ideas what’s causing the pain. Can you help? ANSWER: Back pain is ...